Anhui Fengyuan Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 962.64 million compared to CNY 863.88 million a year ago. Revenue was CNY 962.64 million compared to CNY 863.88 million a year ago. Net income was CNY 35.75 million compared to CNY 27.29 million a year ago. Basic earnings per share from continuing operations was CNY 0.1145 compared to CNY 0.0874 a year ago. Diluted earnings per share from continuing operations was CNY 0.1145 compared to CNY 0.0874 a year ago.